Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia

The Brief Psychiatric Rating Scale

John E. Overall, Donald R. Gorham · Psychological Reports · 1962 · 10.9K citations

Psychiatric Evaluation, Psychiatry, Clinical Psychology +6

Clozapine for the Treatment-Resistant Schizophrenic

John M. Kane · Archives of General Psychiatry · 1988 · 4.1K citations

Implications of Normal Brain Development for the Pathogenesis of Schizophrenia

Daniel R. Weinberger · Archives of General Psychiatry · 1987 · 3.7K citations

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans

John H. Krystal · Archives of General Psychiatry · 1994 · 3.3K citations

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

Ian Creese, David R. Burt, Solomon H. Snyder · Science · 1976 · 2.2K citations

Tritiated Haloperidol Binding, Psychopharmacology, Pharmacotherapy +17